Results 131 to 140 of about 76,979 (321)
An open-label randomized clinical trial of prophylactic paracetamol coadministered with 7-valent pneumococcal conjugate vaccine and hexavalent diphtheria toxoid, tetanus toxoid, 3-component acellular pertussis, hepatitis B, inactivated poliovirus, and Haemophilus influenzae type b vaccine [PDF]
, 2013 BACKGROUND: In two clinical trials, low-grade fever was observed more frequently after coadministration than after separate administration of two recommended routine pediatric vaccines.
Baker, Sherryl +5 more
core +1 more source
PLoS ONE, 2017 Background The 13-valent pneumococcal conjugate vaccine (PCV13) was licensed based on the results of immunogenicity studies and correlates of protection derived from randomized clinical trials of the 7-valent conjugate pneumococcal vaccine.
Á. Domínguez +18 more
semanticscholar +1 more source
Pneumococcal vaccination in adults: rationale, state of the art and perspectives [PDF]
, 2012 Streptococcus pneumoniae (SP) is a leading cause of morbid- ity and mortality worldwide. Despite the availability, since the early 1980s, of a 23-valent pneumococcal polysaccharide vaccine (PPV23), its recommendation and increased use in the last decades,
Bagnasco, A +4 more
core +2 more sources
Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine. [PDF]
, 2018 Streptococcus pneumoniae is the leading cause of bacterial pneumonia. Although this is a vaccine preventable disease, S. pneumoniae still causes over 1 million deaths per year, mainly in children under the age of five.
Abouelhadid, Sherif +7 more
core +3 more sources
BMC Infectious Diseases, 2016 BackgroundAn outbreak of pneumococcal meningitis among non-infant children and adults occurred in the Brong-Ahafo region of Ghana between December 2015 and April 2016 despite the recent nationwide implementation of a vaccination programme for infants ...
B. Kwambana-Adams +26 more
semanticscholar +1 more source
Update on the success of the pneumococcal conjugate vaccine
Paediatrics & Child Health, 2011 Several years after the seven-valent pneumococcal conjugate vaccine (PCV7) was introduced in Canada and elsewhere, routine infant vaccination has led to near eradication of invasive pneumococcal disease caused by vaccine serotype strains in both children and adults.
openaire +3 more sources
Open Forum Infectious Diseases, 2016 Implementation of 13-valent conjugate pneumococcal vaccine in France has led to an overall antibiotic resistance decrease among invasive pneumococcal isolates.
C. Janoir +3 more
semanticscholar +1 more source
Experience with pneumococcal conjugate vaccine in Norway
Expert Review of Vaccines, 2009 Seven-valent pneumococcal conjugate vaccine (PCV7) was introduced into the Norwegian childhood vaccination program in July 2006 in a 2+1 dose (three-dose) schedule. Vaccine coverage quickly reached high levels and the incidence rate of invasive pneumococcal disease in children under 2 years of age declined rapidly.
openaire +3 more sources
Effectiveness of Pneumococcal Polysaccharide Vaccine for Preschool-Age Children with Chronic Disease
Emerging Infectious Diseases, 1999 To estimate the effectiveness of pneumococcal polysaccharide vaccine, we serotyped isolates submitted to the Pneumococcal Sentinel Surveillance System from 1984 to 1996 from 48 vaccinated and 125 unvaccinated children 2 to 5 years of age.
Anthony E. Fiore +4 more
doaj +1 more source